In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

The Health Landscape

National Prescribing Indicators

National Prescribing Indicators 2020-21

Due to the workload pressures across NHS Wales during the COVID-19 pandemic, the NPIs for 2020–2021 have been carried forward into 2021–2022. Therefore, the following supporting documentation is as it was provided for 2020–2021. However, the ‘Specifications’ document has been updated and includes refreshed threshold targets for 2021–2022.

The National Prescribing Indicators for 2020–2021 have been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG) and the All Wales Therapeutics and Toxicology Centre (AWTTC), and subsequently endorsed by the All Wales Medicines Strategy Group (AWMSG)
National Prescribing Indicators (NPIs) are developed annually with the aim of promoting rational prescribing. The indicators are evidence-based and are designed to be clear, easily understood and allow health boards, primary care clusters, GP practices and prescribers to compare current prescribing practice against an agreed standard of quality

For 2020-21 (now 2021-22) the National prescribing indicators: supporting safe and optimised prescribing, have been refreshed with a focus on 3 priority areas
  • Analgesics (including Opioid burden, Tramadol and Gabapentin and pregabalin)
  • Anticoagulants in atrial fibrillation
  • Antimicrobial stewardship (including Total antibacterial items and 4C antimicrobials)
These three priority areas are also supported by additional indicators falling into the categories of safety and efficiency:
  • Safety
    • Prescribing Safety Indicators
    • Proton pump inhibitors
    • Hypnotics and anxiolytics
    • Yellow Cards
  • Efficiencies
    • Best value biological medicines
    • Insulin
    • Low value for prescribing
The National Prescribing Indicators document provides detailed background information and evidence to support the aims of each indicator, and is available here:

The National Prescribing Indicators 2021–2022: Analysis of Prescribing Data to June 2021 document has been prepared by the Welsh Analytical Prescribing Support Unit and can be accessed via the link below:
National Prescribing Indicators 2021–2022: Quarterly reports